Engineering chimeric antigen receptor CD4 T cells for Alzheimer's disease [dataset]

In this study, we present amyloid-β-specific engineered CD4+ CAR-T as an approach to directly target sites of pathology. The data is presented in a single spreadsheet file containing all raw data for main and supplementary figures.本研究报道了一种可直接靶向病理位点的策略：靶向β淀粉样蛋白的工程化CD4+嵌合抗原受体T细胞（CAR-T）。本研究的全部原始数据（涵盖主图与补充图所需的所有原始数据）均收纳于单个电子表格文件中。